In the present research, a series of 5,6-bis aryl 1,2,4-triazines 5a~5f were synthesized by condensation of various benzils 4a~4f with aminoguanidine bicarbonate and were screened in vivo, for their anticonvulsant and neurotoxicity studies. Compounds 5a, 5b and 5d were found to be potent molecules of this series, when compared with the reference drugs phenytoin sodium, diazepam and lamotrigine. The structures of these compounds were established by IR, 1 H NMR, 13 C NMR and mass spectroscopic data.
INTRODUCTION
Epilepsy, characterized by the periodic and unpredictable occurrence of seizures is the most prevalent neurological disorder, affecting 0.5% to 1% of the worldwide population (45~100 million) (Chang and Lowenstein, 2003; McNamara, 2001) . Conventional antiepileptic drugs (AEDs) though widely used by approximately 25% of epileptics (Sander, 1993; Pastalos, 1999) fail to adequately control seizures and exhibit unfavourable side effects such as ataxia, hepatotoxicity, gingival hyperplasia and megaloblastic anemia (Duncan, 2002; Danny et al., 1992) .
Phenytoin and carbamazepine prolong the inactive state of the voltage-dependent Na + channels. A similar action was found for felbamate and topiramate. Topiramate also affects chloride currents and increases the number of channel openings induced by GABA (gama amino butyric acid) (Petroff et al., 1995) . Contrary to this lamotrigine acts by prolonging inactivation of voltage-sensitive Na + channels. Selectivity differences for the α subunits of Na + channels might be responsible for the two different mechanisms (Taylor, 1996) . The 1,2,4-triazines seem to act by inhibition of the Na + channel in a frequency-dependent manner. As proposed previously, the pharmacophoric elements responsible for this mechanism are lipophilic aryl ring and hydrogen bonding to triazine moiety. The attachment of a second aryl ring to increase the van der Waal's bonding at the binding site, substitutions by diverse electron rich groups on aryl ring has proven to increase potency in the maximal electroshock seizure (MES) screen (Pandeya et al., 2000; Dimmock et al., 1995a) . These structural contemplations gave impetus to synthesize some novel and potent 1,2,4-triazines, with phenyl having substitutions at C-5 and C-6 with halogen groups (electron withdrawing), which were considered to have sufficient diverse electronic, steric and hydrophobic characters.
CHEMISTRY
The synthesis of various 1,2,4-triazines was Fig.1 , by condensation of aldehydes 1 and 2 to yield compounds 3a~3f, which structures were confirmed by disappearance of a peak between δ 9.6 to 9.9 for −CHO proton (Erickson, 1952) . Compounds 3a~3f on reacting with c-HNO 3 (concentrated HNO 3 ) yield corresponding benzils 4a~4f, which were confirmed by disappearance of a singlet of −OH between δ 2.0 to 2.3 and CH proton between δ 6.0 to 6.2 in the 1 H NMR spectra (Sawyer and Copp, 1992) . Substituted benzil derivatives 4a~4f on condensation with aminoguanidine bicarbonate yield corresponding 5,6-bis aryl 1,2,4-triazines 5a~5f. The structures of 5a~5f were established by the appearance of a singlet between δ 4.0 to 4.3 for 2 protons of −NH 2 in the 1 H NMR spectra and disappearance of the peak at δ 195.2 (C=O) which was present in 4a~4f (Richard et al., 1972) . The spectral data of each compound was shown in the EXPERIMENTAL PROTOCOLS section and physical data was presented in Table 1 .
PHARMACOLOGY
All the 5,6-bis aryl 1,2,4-triazines 5a~5f, obtained from the reactional sequence were injected intraperitoneally into mice and evaluated for acute toxicity test, initial anticonvulsant screening and minimal motor impairment by the rotorod (neurotoxicity, NT) test, with three dose levels (30, 100 and 300 mg/kg) at two different time intervals.
The profile of anticonvulsant activity was established by MES pattern test and subcutaneous pentylene tetrazole (ScPTZ) seizure threshold test. All the compounds 5a~5f were evaluated for their CNS (central nervous system) behavioral activity in mice using actophotometer and Porsolt's swim pool test with rats.
RESULTS AND DISCUSSION
Compounds 5a~5f were first tested for prelimi- (Table 2) as per testing procedures described in National Institute of Neurological Disorders, Stroke, NH, Bethesda, MD, USA, for Anticonvulsant Screening Project (ASP). Compounds rendering protection in the MES test may prove to be useful in treating generalized tonic-clonic and complex partial seizures, and activity in the ScPTZ screening is deemed to denote the agents of value in treating seizures. The data in Table 3 reveal that all the compounds were active in both MES and ScPTZ screening at 30 min, thus indicating that synthesized compounds are rapid acting anticonvulsants. Neurotoxicity in mice was measured by the rotorod apparatus, with compounds 5d and 5f exhibiting neurotoxicity at dose of 300 mg/kg, when compared to other compounds.
In MES screening, all the compounds showed protection varying in the range of 8% to 84%, among them compounds 5a, 5b, and 5d showed excellent protection. The characteristic feature of these compounds is substitution of electron rich atom/group at different positions of aryl ring, which demonstrates potent anticonvulsant activity in comparison to other derivatives (Dimmock et al., 1995b) .
The bioevaluation data of the synthesized compounds by ScPTZ induced seizures led to comprehending why compounds 5b and 5e were equipotent in protection to phenytoin. The assessment led to understanding the importance of methoxy substitution on aryl ring, i.e. with dimethoxy, the optimum electron donor guaranteed superior anticonvulsant activity in 5e. The introduction of 3rd methoxy group led to 5f, which was found to be inactive. This observation suggests that the additional methoxy group caused interference with alignment at binding site. The optimum logP values in both 5b and 5e ensure lipophilicity required by the compounds. Although the drug levels in cerebrospinal fluid (CSF) or in 
The figures are the doses affording protection or causing neurotoxicity in 50% or more of the animals. The animals were examined 0.5 and 4 h after injections were made. The designation "−" indicates the absence of activity or toxicity at the maximum dose administered (300 mg/kg) In the locomotor study using actophotometer (Table 4) , the compound 5a produced no behavioral despair effect when compared to phenytoin. Compound 5f exhibited decreased locomotor activity in the 30 min interval, but did not exhibit significant behavior despair in 1 h time period. All other compounds were found to decrease locomotor activity. In a similar study using swim pool test, the immobility time after administration of the test compounds was compared with carbamazepine. The compound 5d produced no significant CNS depression compared with control at P<0.004. All other tested compounds were found to emerge as CNS depressants, as they increased the immobility time (Table 5) .
EXPERIMENTAL PROTOCOLS

Chemistry
Melting points were determined in open capillary tubes with a Thomas Hoover melting point apparatus and were uncorrected. Infrared spectra were recorded in KBr on (Nicolet MX-1) FTIR instrument, 1 H NMR spectra (in CDCl 3 ) were recorded by Varian Gemini 200 (200 Hz) NMR spectrometer. Electron impact (EI) mass spectra were determined on AMD-604 mass spectrometer operating at 70 eV.
1. 2-Hydroxy-1,2-diphenylethanone derivatives 3a~3f
The equimolar mixture of compounds 1 and 2 (0.47 mol), rectified spirit (65 ml) and sodium cyanide (0.1 mol) in 50 ml of water was refluxed for 2 h. Then the mixture was cooled in ice bath and filtered, the solid thus obtained was washed with water and recrystalized with hot ethanol to obtain compounds 3a~3f.
Substituted benzil derivatives 4a~4f
A mixture of 3a~3f (0.014 mol) and c-HNO 3 (2 mol) were refluxed until the oxides of nitrogen ceased to evolve and poured into ice-cold water, the solid thus obtained was filtered off and washed with water and recrystalized with ethanol to yield compounds 4a~4f.
3. 5,6-Diphenyl-1,2,4-triazin-3-amine derivatives 5a~5f
The mixture of aminoguanidine bicarbonate (0.08 mol), 4a~4f (0.035 mol) and 30.0 ml of rectified spirit was acidified to pH 3~4 with c-HCl and refluxed for 2 h. Mixture was made alkaline with aq. ammonia and the solid so obtained was further recrystalized with ethanol.
Spectal data
1. 5,6-Dip-tolyl-1,2,4-triazin-3-amine 5a FT-IR (KBr): 1620. 
Pharmacology
Acute toxicity test
The compounds were investigated for their acute toxicity (ALD 50 ) in albino mice by following the method of Smith (1960) .
2. Neurotoxicity screening (Grundmann and Kreutzberger, 1954; Hosford and Wang, 1997) Minimal motor impairment was measured in mice by the rotorod apparatus. The mice were trained to stay on an accelerating rotorod rotating at 10 r/min with rod diameter being 3.2 cm. The trained animals were injected intraperitoneally with the test compounds 5a~5f at doses 30, 100 and 300 mg/kg. Neurotoxicity was indicated by the inability of the animal to maintain equilibrilium on the rod for at least 1 min in each of the three trials.
3. Anticonvulsant activity (1) MES test (Kubicki and Codding, 2001; Stephani, 1989) This activity was performed according to the reported method on albino rats of either sex, weighing between 80 to 120 g. Rats were divided into 8 groups of 6 animals each. The rats were treated with compounds 5a~5f at dose of 10 mg/kg or phenytoin 40 mg/kg i.p. After 1 h they were subjected to shock of 150 mA by convulsiometer through ear electrodes for 0.2 s, the duration of extensor phase response was noted and animals in which extensor response was abolished were taken as protected rats.
(2) ScPTZ induced seizures test (Fisher, 1989) The test was performed using albino mice which were divided into eight groups of 6 each. Pentylenetetrazole (80 mg/kg) (convulsant), diazepam (standard drug) and test compounds 5a~5f were dissolved in 0.5% methyl cellulose/water and injected intraperitoneally at volume of 0.01 ml/g.
The time needed for the development of unequivocal sustained clonic seizure activity involving limbs (isolated myoclonic jerks or other preconclusive chewing behavior were not counted) and duration of seizure was carefully noted. Seizure free period of 1 h was considered as protection. The number of animals protected in each group was recorded and percentage of protection was calculated.
4. Locomotor activity (Stephani, 1989) The titlered compounds 5a~5f at 10 mg/kg were screened for their behavioral effects using actophotometer at 30 min and 1 h after injection. The locomotor activity was recorded by photocell as a digital score, and increased scores suggest good behavioral activity. The control was administered 0.5% methyl cellulose/water in a volume of 0.01 ml/g. 5. CNS depressant study The forced swim pool method described in Porsolt et al.(1978) was followed. Albino rats were placed in a chamber (diameter: 45 cm, height: 20 cm) containing water up to a height of 15 cm at (25±2) °C. Two swim sessions were conducted, an initial 15 min pre-test, followed by a 5 min test session 24 h later. The animals were treated with intraperitoneal injection of test compounds at dose of 10 mg/kg before 30 min of test session. The period of immobility (passive floating without struggling, making only those movements which are necessary to keep its head above the surface of water) during the 5 min test period was measured.
CONCLUSION
In summary, this study highlights the importance of the structural features responsible for the anticonvulsant activity; p-methoxy derivative 5e was found to be most potent in both anticonvulsant activity-evaluating models, which serve as prototypic compounds for subsequent molecular modifications.
